Here are five key points:
1. She sold the shares at $114.90 per share.
2. Within the last 30 days, Ms. Stryker sold another 120,000 shares worth about $14.02 million.
3. Ms. Stryker has rights to 24.42 million shares, which accounts for 6.61 percent of Stryker’s market capitalization.
4. Six analysts currently rate Stryker a “buy,” three rate it a “sell,” and five rate it “hold.”
5. The company’s $108.56 average target is 4.34 percent under today’s stock price.
More articles on devices:
Dr. Rolando Garcia implants new lumbar artificial disc for back pain patients: 4 takeaways
Global orthopedic biomaterial market to reach $38.1B by 2020 — 8 highlights
NovaBone products now available in Brazil: 3 quick notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
